FindTrial
Sign In

Risk factors evaluation for lepra reactions

Evaluation of risk factors and serological determinant ( anti PGL1) in Lepra Reactions in tertiary care institute - Nil

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
CTRI
Registry ID
CTRI/2025/09/094381
Enrollment
60
Registered
2025-09-08
Start date
Unknown
Completion date
Unknown
Last updated
2025-09-15

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: A305- Lepromatous leprosy

Interventions

Intervention1: Nil: Nil Control Intervention1: Nil: Nil

Sponsors

Ayush Bhatnagar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: All leprosy patients (both new and old)

Exclusion criteria

Exclusion criteria: Pregnant and lactating females Patients not willing to participate

Design outcomes

Primary

MeasureTime frame
To determine risk factors in lepra reactions Age Gender Socio-economic status Spectrum of leprosyTimepoint: Baseline—

Secondary

MeasureTime frame
To determine Anti- PGL1 levelsTimepoint: 6months—

Countries

India

Contacts

Public ContactDr Ayush Bhatnagar

All India Institute of Medical Sciences, Raipur

namrata81@aiimsraipur.edu.in8826045002

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026